Cell cycle progression data on human skin cancer cells with anticancer synthetic peptide LTX-315 treatment
Skin cancer, including melanoma and non-melanoma (NMSC), represents the most common type of malignancy in the white population [1]. The incidence rate of melanoma is increasing worldwide, while the associated mortality remains stable. On the other hand, the incidence of NMSC varies widely [1,2]. Cam...
Main Authors: | Gloria A. Santa-González, Edwin Patiño-González, Marcela Manrique-Moreno |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | Data in Brief |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352340920303371 |
Similar Items
-
Oncolytic peptide LTX-315 induces an immune-mediated abscopal effect in a rat sarcoma model
by: Janne Nestvold, et al.
Published: (2017-08-01) -
Combining the oncolytic peptide LTX-315 with doxorubicin demonstrates therapeutic potential in a triple-negative breast cancer model
by: Ketil A. Camilio, et al.
Published: (2019-01-01) -
LTX-315 – a promising novel antitumor peptide and immunotherapeutic agent
by: Dagmar Zweytick
Published: (2019-11-01) -
Synthetic Peptide ΔM4-Induced Cell Death Associated with Cytoplasmic Membrane Disruption, Mitochondrial Dysfunction and Cell Cycle Arrest in Human Melanoma Cells
by: Gloria A. Santa-González, et al.
Published: (2020-12-01) -
Effect of Aggregatibacter actinomycetemcomitans Leukotoxin on ATP Release through Pannexin Channels in Human Monocytes
by: Bäck, Linnéa, et al.
Published: (2016)